Angiotensin-(1-7) Selectively Induces Relaxation and Modulates Endothelium-Dependent Dilation in Mesenteric Arteries of Salt-Fed Rats

Overview

Journal J Vasc Res

Specialty Cardiology & Vascular Diseases

Date 2016 Sep 28

PMID 27676088

Citations 7

Authors

Gabor Raffai

Julian H Lombard

Affiliations

Soon will be listed here.

Abstract

This study investigated the acute effects of angiotensin-(1-7) and AVE0991 on active tone and vasodilator responses to bradykinin and acetylcholine in isolated mesenteric arteries from Sprague-Dawley rats fed a high-salt (HS; 4% NaCl) versus a normal salt (NS; 0.4% NaCl) diet. Angiotensin-(1-7) and AVE0991 elicited relaxation, and angiotensin-(1-7) unmasked vasodilator responses to bradykinin in arteries from HS-fed rats. These effects of angiotensin-(1-7) and AVE0991 were inhibited by endothelium removal, A779, PD123319, HOE140 and L-NAME. Angiotensin-(1-7) also restored the acetylcholine-induced relaxation that was suppressed by the HS diet. Vasodilator responses to bradykinin and acetylcholine in the presence of angiotensin-(1-7) were mimicked by captopril and the AT2 receptor agonist CGP42112 in arteries from HS-fed rats. Thus, in contrast to salt-induced impairment of vascular relaxation in response to vasodilator stimuli, angiotensin-(1-7) induces endothelium-dependent and NO-mediated relaxation, unmasks bradykinin responses via activation of mas and AT2 receptors, and restores acetylcholine-induced vasodilation in HS-fed rats. AT2 receptor activation and angiotensin-converting enzyme (ACE) inhibition shared the ability of angiotensin-(1-7) to enhance bradykinin and acetylcholine responses in HS-fed rats. These findings suggest a therapeutic potential for mas and/or AT2 receptor activation and ACE inhibition in restoring endothelial function impaired by elevated dietary salt intake or other pathological conditions.

Citing Articles

Mas receptor: a potential strategy in the management of ischemic cardiovascular diseases.

Molaei A, Molaei E, Wallace Hayes A, Karimi G Cell Cycle. 2023; 22(13):1654-1674.

PMID: 37365840 PMC: 10361149. DOI: 10.1080/15384101.2023.2228089.

Salt Restriction and Angiotensin-Converting Enzyme Inhibitor Improve the Responsiveness of the Small Artery in Salt-Sensitive Hypertension.

Li S, Jiang T, Zhang J, Zeng M, Ma Y, Feng S Int J Med Sci. 2023; 20(5):572-580.

PMID: 37082725 PMC: 10110468. DOI: 10.7150/ijms.79741.

Evaluation of the cardioprotective and antihypertensive effect of AVE 0991 in normotensive and hypertensive rats.

da Silva M, Sousa Junior C, Silva H, Dos Santos V, Feijao F, Bernardino A Rev Assoc Med Bras (1992). 2022; 68(7):xxx.

PMID: 35830019 PMC: 9574952. DOI: 10.1590/1806-9282.20220259.

Vascular Effects of Low-Dose ACE2 Inhibitor MLN-4760-Benefit or Detriment in Essential Hypertension?.

Berenyiova A, Bernatova I, Zemancikova A, Drobna M, Cebova M, Golas S Biomedicines. 2022; 10(1).

PMID: 35052717 PMC: 8773407. DOI: 10.3390/biomedicines10010038.

ACE2, angiotensin 1-7 and skeletal muscle: review in the era of COVID-19.

Yamamoto K, Takeshita H, Rakugi H Clin Sci (Lond). 2020; 134(22):3047-3062.

PMID: 33231620 PMC: 7687025. DOI: 10.1042/CS20200486.

References

Oliveira M, Fortes Z, Santos R, Kosla M, de Carvalho M . Synergistic effect of angiotensin-(1-7) on bradykinin arteriolar dilation in vivo. Peptides. 1999; 20(10):1195-201. DOI: 10.1016/s0196-9781(99)00123-0. View

Polizio A, Gironacci M, Tomaro M, Pena C . Angiotensin-(1-7) blocks the angiotensin II-stimulated superoxide production. Pharmacol Res. 2007; 56(1):86-90. DOI: 10.1016/j.phrs.2007.04.004. View

Vanhoutte P, Auch-Schwelk W, Biondi M, Lorenz R, Schini V, Vidal M . Why are converting enzyme inhibitors vasodilators?. Br J Clin Pharmacol. 1989; 28 Suppl 2:95S-103S; discussion 103S-104S. PMC: 1379847. DOI: 10.1111/j.1365-2125.1989.tb03585.x. View

Santos R, Campagnole-Santos M, Baracho N, Fontes M, Silva L, Neves L . Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors. Brain Res Bull. 1994; 35(4):293-8. DOI: 10.1016/0361-9230(94)90104-x. View

Giani J, Burghi V, Veiras L, Tomat A, Munoz M, Cao G . Angiotensin-(1-7) attenuates diabetic nephropathy in Zucker diabetic fatty rats. Am J Physiol Renal Physiol. 2012; 302(12):F1606-15. DOI: 10.1152/ajprenal.00063.2012. View

Erdos E, Tan F, Skidgel R . Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function. Hypertension. 2010; 55(2):214-20. PMC: 2814794. DOI: 10.1161/HYPERTENSIONAHA.109.144600. View

Walters P, Gaspari T, Widdop R . Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats. Hypertension. 2005; 45(5):960-6. DOI: 10.1161/01.HYP.0000160325.59323.b8. View

Priestley J, Buelow M, McEwen S, Weinberg B, Delaney M, Balus S . Reduced angiotensin II levels cause generalized vascular dysfunction via oxidant stress in hamster cheek pouch arterioles. Microvasc Res. 2013; 89:134-45. PMC: 3758804. DOI: 10.1016/j.mvr.2013.04.004. View

Gross V, Kurth T, Skelton M, Mattson D, Cowley Jr A . Effects of daily sodium intake and ANG II on cortical and medullary renal blood flow in conscious rats. Am J Physiol. 1998; 274(5):R1317-23. DOI: 10.1152/ajpregu.1998.274.5.R1317. View

10.

Zhu J, Drenjancevic-Peric I, McEwen S, Friesema J, Schulta D, Yu M . Role of superoxide and angiotensin II suppression in salt-induced changes in endothelial Ca2+ signaling and NO production in rat aorta. Am J Physiol Heart Circ Physiol. 2006; 291(2):H929-38. DOI: 10.1152/ajpheart.00692.2005. View

11.

Maia L, Ramos M, Fernandes L, de Carvalho M, Campagnole-Santos M, Dos Santos R . Angiotensin-(1-7) antagonist A-779 attenuates the potentiation of bradykinin by captopril in rats. J Cardiovasc Pharmacol. 2004; 43(5):685-91. DOI: 10.1097/00005344-200405000-00011. View

12.

Tom B, Dendorfer A, de Vries R, Saxena P, Danser A . Bradykinin potentiation by ACE inhibitors: a matter of metabolism. Br J Pharmacol. 2002; 137(2):276-84. PMC: 1573486. DOI: 10.1038/sj.bjp.0704862. View

13.

Auch-Schwelk W, Kuchenbuch C, Claus M, Walther B, Bossaller C, Friedel N . Local regulation of vascular tone by bradykinin and angiotensin converting enzyme inhibitors. Eur Heart J. 1993; 14 Suppl I:154-60. View

14.

Paula R, Lima C, Khosla M, Santos R . Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats. Hypertension. 1995; 26(6 Pt 2):1154-9. DOI: 10.1161/01.hyp.26.6.1154. View

15.

Roks A, Geel P, Pinto Y, Buikema H, Henning R, de Zeeuw D . Angiotensin-(1-7) is a modulator of the human renin-angiotensin system. Hypertension. 1999; 34(2):296-301. DOI: 10.1161/01.hyp.34.2.296. View

16.

Almeida A, Frabregas B, Madureira M, Santos R, Campagnole-Santos M, Santos R . Angiotensin-(1-7) potentiates the coronary vasodilatatory effect of bradykinin in the isolated rat heart. Braz J Med Biol Res. 2000; 33(6):709-13. DOI: 10.1590/s0100-879x2000000600012. View

17.

Raffai G, Durand M, Lombard J . Acute and chronic angiotensin-(1-7) restores vasodilation and reduces oxidative stress in mesenteric arteries of salt-fed rats. Am J Physiol Heart Circ Physiol. 2011; 301(4):H1341-52. PMC: 3197355. DOI: 10.1152/ajpheart.00202.2011. View

18.

Ferrario C . ACE2: more of Ang-(1-7) or less Ang II?. Curr Opin Nephrol Hypertens. 2010; 20(1):1-6. PMC: 5826562. DOI: 10.1097/MNH.0b013e3283406f57. View

19.

Fernandes L, Fortes Z, Nigro D, Tostes R, Santos R, Catelli De Carvalho M . Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo. Hypertension. 2001; 37(2 Pt 2):703-9. DOI: 10.1161/01.hyp.37.2.703. View

20.

Collister J, Hendel M . The role of Ang (1-7) in mediating the chronic hypotensive effects of losartan in normal rats. J Renin Angiotensin Aldosterone Syst. 2003; 4(3):176-9. DOI: 10.3317/jraas.2003.028. View